Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 9;7(1):29-35.
doi: 10.1002/ped4.12368. eCollection 2023 Mar.

Response to magnesium sulfate and adrenocorticotropic hormone combination therapy for infantile spasms with failed first-line treatments

Qiuhong Wang  1 , Wen He  1 , Yangyang Wang  1 , Liying Liu  1 , Mengna Zhang  1 , Xiaoyan Yang  1 , Liping Zou  1   2
Affiliations

Response to magnesium sulfate and adrenocorticotropic hormone combination therapy for infantile spasms with failed first-line treatments

Qiuhong Wang et al. Pediatr Investig. .

Abstract

Importance: Infantile spasm (IS) is a kind of refractory epilepsy. The first-line treatments for IS are adrenocorticotropic hormone (ACTH), oral corticosteroids, and vigabatrin.

Objective: This study aimed to evaluate the efficacy of magnesium sulfate and ACTH (MgSO4+ACTH) combination therapy in patients with IS who failed first-line treatments.

Methods: In this retrospective study, the clinical data of patients with IS who failed first-line treatments were collected in the Chinese PLA General Hospital. Patients received MgSO4+ACTH combination therapy after first-line treatments failed. The course of treatments was 2 weeks. The therapeutic dose of ACTH and MgSO4 was 2.5 U·kg-1·d-1 and 0.25 g·kg-1·d-1, respectively.

Results: A total of 229 patients with IS who failed the first-line treatments were collected. At the end of the MgSO4+ACTH combination treatment, the seizure-free rate was 48.5% (111/229), and the resolution of hypsarrhythmia on electroencephalogram (EEG) was 72.1% (165/229). About 21.4% (49/229) of patients showed side effects, including infectious diseases, hypokalemia, and diarrhea.

Interpretation: For patients with IS who failed first-line treatments, in terms of the seizure-free rate and resolution of hypsarrhythmia on EEG, MgSO4+ACTH combination therapy can be considered.

Keywords: Adrenocorticotropic hormone; Efficacy; Infantile spasms; Magnesium sulfate; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow chart of participant eligibility and inclusion. ACTH, adrenocorticotrophic hormone; OCS, oral corticosteroids; VGB, vigabatrin; MgSO4, magnesium sulfate.
See this image and copyright information in PMC

References

    1. Pavone P, Striano P, Falsaperla R, Pavone L, Ruggieri M. Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. Brain Dev. 2014;36:739‐751. DOI: 10.1016/j.braindev.2013.10.008 - DOI - PubMed
    1. Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, et al. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016;79:475‐484. DOI: 10.1002/ana.24594 - DOI - PMC - PubMed
    1. Go CY, Mackay MT, Weiss SK, Stephens D, Adams‐Webber T, Ashwal S, et al. Evidence‐based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2012;78:1974‐1980. DOI: 10.1212/WNL.0b013e318259e2cf - DOI - PMC - PubMed
    1. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004;364:1773‐1778. DOI: 10.1016/S0140-6736(04)17400-X - DOI - PubMed
    1. O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open‐label trial. Lancet Neurol. 2017;16:33‐42. DOI: 10.1016/S1474-4422(16)30294-0 - DOI - PubMed